Similar Posts
Grant-Funded Growth, Audit-Proven Results
THE CLIENT A next-generation gene therapy company led by a CEOthreesixty alumnus. With a team of 10 primarily consisting of scientists and lab managers, the company operates lean, with no internal finance or accounting staff. Since 2021, they have partnered with Sayva to manage their fractional finance and accounting needs – critical to maintaining compliance…

